NO802277L - Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav - Google Patents

Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav

Info

Publication number
NO802277L
NO802277L NO802277A NO802277A NO802277L NO 802277 L NO802277 L NO 802277L NO 802277 A NO802277 A NO 802277A NO 802277 A NO802277 A NO 802277A NO 802277 L NO802277 L NO 802277L
Authority
NO
Norway
Prior art keywords
halocholest
dioles
3beta
esters
procedure
Prior art date
Application number
NO802277A
Other languages
English (en)
Norwegian (no)
Inventor
Robert John Chorvat
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO802277L publication Critical patent/NO802277L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/40Ortho- or ortho- and peri-condensed systems containing four condensed rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO802277A 1979-07-30 1980-07-29 Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav NO802277L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/061,731 US4230626A (en) 1979-07-30 1979-07-30 25-Halocholest-5-ene-3β,22-diols and esters thereof

Publications (1)

Publication Number Publication Date
NO802277L true NO802277L (no) 1981-02-02

Family

ID=22037752

Family Applications (1)

Application Number Title Priority Date Filing Date
NO802277A NO802277L (no) 1979-07-30 1980-07-29 Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav

Country Status (23)

Country Link
US (1) US4230626A (it)
JP (1) JPS5622799A (it)
AT (1) ATA395380A (it)
AU (1) AU532108B2 (it)
BE (1) BE884532A (it)
CA (1) CA1144539A (it)
CH (1) CH645651A5 (it)
DE (1) DE3028643A1 (it)
DK (1) DK146390C (it)
ES (1) ES8106540A1 (it)
FI (1) FI802368A (it)
FR (1) FR2462444A1 (it)
GB (1) GB2056992B (it)
GR (1) GR69347B (it)
IE (1) IE50037B1 (it)
IL (1) IL60700A0 (it)
IT (1) IT1128554B (it)
NL (1) NL8004366A (it)
NO (1) NO802277L (it)
NZ (1) NZ194490A (it)
PT (1) PT71621A (it)
SE (1) SE430508B (it)
ZA (1) ZA804617B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348328A (en) * 1981-11-09 1982-09-07 G.D. Searle & Co. 25-Substituted-5α-cholestane-3β,22S-diol
US5034548A (en) * 1987-01-30 1991-07-23 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
US5041432A (en) * 1987-01-30 1991-08-20 E. I. Du Pont De Nemours And Company Steroid derivatives useful as hypocholesterolemics
US5219879A (en) * 1990-03-05 1993-06-15 Du Pont Merck Pharmaceutical Company Heterocyclic steroid compounds
ATE238339T1 (de) 1996-12-20 2003-05-15 Novo Nordisk As Verbindungen zur regulierung der meiose
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
CN113956133A (zh) * 2021-11-08 2022-01-21 湖南科瑞生物制药股份有限公司 25-羟基甾体化合物的合成方法、其侧链的制备方法以及侧链中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
CH643566A5 (de) * 1977-08-29 1984-06-15 Searle & Co 25-alkylcholesterin-derivate.

Also Published As

Publication number Publication date
NL8004366A (nl) 1981-02-03
IT1128554B (it) 1986-05-28
AU532108B2 (en) 1983-09-15
IE50037B1 (en) 1986-02-05
SE430508B (sv) 1983-11-21
BE884532A (fr) 1981-01-29
JPS5622799A (en) 1981-03-03
NZ194490A (en) 1983-03-15
JPS6360037B2 (it) 1988-11-22
DE3028643A1 (de) 1981-02-19
ES493810A0 (es) 1981-06-16
IT8049382A0 (it) 1980-07-30
CA1144539A (en) 1983-04-12
IL60700A0 (en) 1980-09-16
ZA804617B (en) 1982-03-31
DK146390B (da) 1983-09-26
DK326980A (da) 1981-01-31
GB2056992A (en) 1981-03-25
DK146390C (da) 1984-03-05
FI802368A (fi) 1981-01-31
SE8005430L (sv) 1981-01-31
PT71621A (en) 1980-08-01
US4230626A (en) 1980-10-28
FR2462444A1 (fr) 1981-02-13
IE801590L (en) 1981-01-30
ES8106540A1 (es) 1981-06-16
FR2462444B1 (it) 1983-05-20
CH645651A5 (de) 1984-10-15
AU6088380A (en) 1981-02-05
GR69347B (it) 1982-05-18
GB2056992B (en) 1983-06-22
DE3028643C2 (it) 1990-04-12
ATA395380A (de) 1983-11-15

Similar Documents

Publication Publication Date Title
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO148148C (no) Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater
NO800451L (no) Antihyperkolesterolmiddel, monacolin k, og fremgangsmaate til fremstilling av samme
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO151461C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater
NO812344L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO148957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider
NO150360C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider
NO157738C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazinoner og benzoksazolinoner.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO782756L (no) Fremgangsmaate for fremstilling av terapeutisk aktive antrakinonderivater
NO801046L (no) Penem-3-karboksylsyrederivater og fremgangsmaate til fremstilling av samme
NO151319C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser
NO148644C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive sukkerderivater.
NO147750C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive og optisk aktive 11-desoksy-16-aryloksy-omega-tetranorprostaglandiner
NO802277L (no) Fremgangsmaate til fremstilling av terapeutisk aktive 25-halocholest-5-en-3beta,22-dioler og estere derav
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO803073L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner og pyrimidiner
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO813263L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO780644L (no) Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater
NO152843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner.